Life Science Insights - Growth & Revenue Trends

AusCann’s DayaCann JV to begin medical cannabis production with Khiron

Paroma Bhattacharya January 22, 2019

DayaCann would be providing cultivation as well as potentially manufacturing services to Khiron, under the terms of the agreement. Australian medical cannabis firm AusCann Group Holdings Ltd. has recently announced that its DayaCann joint venture (JV) is set to commence third party cannabis cultivation, its …

Life Sciences

Kolon Life Science & Mundipharma ink license deal to market Invossa-K

Ojaswita Kutepatil November 20, 2018

Recently, Kolon Life Science announced that it has reportedly signed a technology export contract with pharmaceutical company Mundipharma to launch a cell gene therapy called Invossa-K. The therapy is reportedly aimed at treating osteoarthritis and is developed by Kolon Life Science’s subsidiary Kolon TissueGene based …

Life Sciences

NIH grants $1.4M to support study related to non-invasive endoscopy

Ojaswita Kutepatil November 19, 2018

Professor Larry Miller MD of Feinstein Institute for Medical Research has reportedly received $14 million grant from the National Institutes of Health to develop and experiment on a method enabling non-invasive access to the nerves in the chest and abdomen. As per credible sources, accessing …

Category: Life Sciences